63results about How to "Increase insulin levels" patented technology

A method of glucose level control comprising providing at least one electrode adapted to apply an electric field to a pancreas; and applying an electric field to the pancreas using said at least one electrode such that blood glucose levels are significantly reduced and blood insulin levels are not significantly increased compared to a regular insulin response in a same person.

A method of infusing liquid medicaments including insulin via an insulin pump, includes identifying an insulin delivery protocol associated with ingestion of carbohydrates wherein the insulin delivery protocol is likely to lead to a postprandial drop in blood glucose to a level below a basal level, then proposing at least one alternative insulin delivery protocol to inhibit the postprandial drop in blood glucose by delivering a metered amount of insulin that is appropriate to facilitate the metabolism of the carbohydrates without the postprandial blood glucose level drop. The invention further includes querying the patient as to whether to apply the alternative insulin delivery protocol, receiving instructions from the patient in response to the query, and applying the alternative insulin delivery protocol following receiving instructions from the patient to apply the alternative insulin delivery protocol.

The subject invention provides compositions and methods for treating diabetes in patients. In a preferred embodiment, the invention provides compositions methods for treating diabetes and/or preventing or alleviating complications associated with diabetes. Specifically exemplified herein is the concurrent administration of a cysteamine compound with at least one additional therapeutic agent to prevent and/or treat diabetes as well as prevent and/or treat complications associated with diabetes. In a preferred embodiment, oral administration of cysteamine hydrochloride with Metformin to a patient diagnosed with diabetes can substantially regulate the patient's glucose metabolism and insulin sensitivity.

α2-Heremans Schmid Glycoprotein (AHSG) inhibits insulin-induced autophosphorylation of the insulin receptor (IR) and IR-tyroskine kinase (TK) activity; genetic ablation of the Ahsg gene enhances insulin signal transduction and increase whole-body insulin sensitivity. Therefor, AHSG and its gene(s) are useful targets for agents that inhibit the development or progression of Type II diabetes or any disease or disorder associated with increased insulin resistance. Provided herein is a method for inhibiting the biological activity of AHSG protein in a cell using compounds that inhibit phosphorylation of AHSG. Also disclosed is a method of augmenting the phosphorylation or IR-TK activity in a liver or muscle cell by providing a compound that lowers the amount of active AHSG or inhibits the biological activity of AHSG. Such effects may be achieved by delivering an antisense nucleic acid construct that hybridizes with AHSG encoding DNA. This invention includes a method (a) treating a subject that is susceptible to, or suffers from, obesity and insulin resistance or (b) increasing insulin sensitivity, and thereby preventing or treating insulin resistance in the subject. The method comprises lowering the amount of active AHSG or inhibiting the biological activity of AHSG in the subject, preferably in liver or muscle, by using AHSG antisense constructs or an anti-AHSG antibody. In a subject eating a high fat diet, the effect on body weight gain and/or insulin resistance is diminished, and total body fat content is lowered, by lowering the amount of active AHSG or inhibiting the action of the AHSG in the subject using the agents noted above.

A method whereby the blood pressure metabolism in an individual showing evidence of dysregulation is improved when that person receives an appropriate oral administration of (−)-hydroxycitric acid. The potassium salt of (−)-hydroxycitric acid is a preferred form of the compound, followed by the sodium salt, then by the amide and other derivatives of the acid. The regulation of blood pressure levels over any given period of time may be improved with a controlled release form of (−)-hydroxycitric acid. Controlled release can be used to provide a sustained and modulated amount of the active to the body as desired and therefore regulate the use of the compound as a hypotensive agent.

The present invention provides a health-care medicine composition and its preparation method. Said method includes the following steps: making photosynthetic bacterial pool, Chinese herbal medicine liquor, mineral solution and honey undergo the process of biological fermentation, then making them be combined with lactic acid microbial pool, yeast microbial pool, Cram-positive actinomycetes bacterial pool and filamentous microbial pool of fermentation line to form five family microbial community to obtain mother culture, then making said mother culture and nucleic acid, vitamin, SOD and amino acid undergo the process of biological emulsification so as to obtain the invented composition. Said composition has extensive application in preparation of medicine for curing broad-spectrum bacterial disease, broad-spectrum viral disease, damaged gene and diseases due to damaged cell, and specially for preventing and curing SARS.

The invention relates to a hypoglycemic traditional Chinese medicine composition and a preparation method thereof. The traditional Chinese medicine composition comprises 18 drug substances, namely rhizoma anemarrhenae, cortex phellodendri, trichosanthes root, prepared rehmannia root, figwort root, asparagus, milk vetch, cortex lycii radicis, adenophora stricta, dendrobe, fragrant solomonseal rhizome, shizandra berry, radix codonopsitis, fructus ligustri lucidi, boxthorn fruit, yam, endothelium corneum gigeriae galli and kudzuvine root, and can be made into capsules, tablets, pills and granules with the addition of commonly used auxiliary materials in pharmaceutics; the preparation method of the composition has the characteristics of simplicity, practicability, scientificity and energy conservation.

A balanced food product and related method for preparation of the same is provided for optimizing the metabolism of the body of the consumer. The balanced food product may include a first fruit component, a second fruit component, and a protein component, as well as a sweetener component, and an oil binding agent component. Each of the components contributes an amount of carbohydrates, protein, and fat so as to yield a particular predetermined ratio therebetween and selectively provide a predetermined glycemic load to the consumer.

The present invention is related to the use of an overground part of Hedychium coronarium Koenig in lowering blood glucose, increasing insulin levels and treating and/or preventing diabetes without overly reducing blood glucose in a subject; i.e., not reducing blood glucose in a fasting subject. The present invention also relates to an extract and composition of the overground part of Hedychium coronarium Koenig and its use in lowering blood glucose, increasing insulin levels and treating and/or preventing diabetes.

The invention relates to a traditional Chinese medicine composition for treating diabetes, and a preparation method and a detection method thereof. The traditional Chinese medicine composition is prepared by rhizoma anemarrhenae, ginseng, cortex phellodendri, radix trichosanthis, unprocessed rehmannia root, radix scrophulariae and the like. The detection method of the traditional Chinese medicine composition comprises the steps of thin-layer identifications of cortex phellodendri, cortex lycii radicis, fructus lycii, fructus schizandrae, glossy privet fruit and root of kudzu vine; and determination of sarsasapogenin content in the traditional Chinese medicine composition. The traditional Chinese medicine composition provided by the invention has the characteristics of simple and practical process, safety and efficiency, significant pharmacology and drug efficacy and clinical effects.

The present invention relates to a plant extract for treating diabetes and a process for making same. The plant extract of the invention is prepared from an overground part of Hedychium coronarium Koenig, which has the efficacies of lowering blood glucose, increasing insulin levels, reducing insulin resistance and treating and/or preventing diabetes without overly reducing blood glucose in a subject, i.e., not reducing blood glucose in a fasting subject. Also provided herein is a method for treating diabetes in a subject in need thereof comprising administering an effective amount of the plant extract to the subject.

The invention discloses a pharmaceutical composition with hypoglycemic function and preparation method thereof. The invention is made from bitter melon, anemarrhena, Tuber of Dwarf Lilyturf, picolinic acid and propolis according to a certain weight proportion; and it can be made into any common oral taken preparation form. The Chinese traditional medicine composition in the invention achieves hypoglycemic function, and can be used to treat diabetes.

The invention relates to a marinating material, a marinated beancurd sheet and a preparation method thereof, and belongs to the technical field of food processing. The marinating material comprises the following main components: tea leaves, xylooligosaccharide, edible salt, soy sauce, hericium erinaceus powder, bamboo shoot powder, a yeast extract, star anise, cinnamon, amomum tsaoko, clove, pepper, dried orange peel, myrcia, radix angelicae, licorice, ginger, amomum villosum, amomum cardamomum, netmeg and edible oil. The components achieve a synergistic effect; through addition of the marinating material during production of a marinated product, the effect of endowing the marinated product with a good mouth feel is achieved, and the health-care effects of inhibiting bacteria, helping digestion, promoting absorption, lowering blood pressure and blood fat and the like are achieved.

The present invention provides a method for improving pancreatic function in a subject in need thereof, the method comprising administering to the subject STRO-1⁺ cells and/or progeny cells thereof and/or soluble factors derived therefrom. The method of the invention is useful for treating and/or preventing and/or delaying the onset or progression of a disorder resulting from or associated with pancreatic dysfunction, e.g., resulting from abnormal endocrine or exocrine function of the pancreas.